郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.

期刊：European journal of pharmacology发表年份：2009作者：Kamna Nanda; Krishna S Naruganahalli; Suman Gupta; Shivani Malhotra; Atul Tiwari; Laxminarayan G Hegde; Sanjay Jain; Neelima Sinha; Jung B Gupta; Anita Chugh; Nitya Anand; Abhijit Ray
阅读更多 →

药效评价Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.

期刊：British journal of pharmacology发表年份：2009作者：Hernán A Navarro; James L Howard; Gerald T Pollard; F Ivy Carroll
阅读更多 →

药效评价Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.

期刊：Bioorganic & medicinal chemistry发表年份：2009作者：Carolina Urquiola; Marisol Vieites; María H Torre; Mauricio Cabrera; María Laura Lavaggi; Hugo Cerecetto; Mercedes González; Adela López de Cerain; Antonio Monge; Pablo Smircich; Beatriz Garat; Dinorah Gambino
阅读更多 →

药效评价BMP6 reverses TGF-beta1-induced changes in HK-2 cells: implications for the treatment of renal fibrosis.

期刊：Acta pharmacologica Sinica发表年份：2009作者：Ji-Dong Yan; Shuang Yang; Jie Zhang; Tian-Hui Zhu
阅读更多 →